Aurinia Pharmaceuticals AUPH Accrued Marketing and Advertising Expenses

Accrued Marketing and Advertising Expenses at other companies

MarqetaMQ

$260.14M+24.2%

Hillman Solutions Corp.HLMN

$5.51M-0.8%

Warby ParkerWRBY

$12.78M+40.2%

Thor IndustriesTHO

$170.94M-2.7%

Mondelez InternationalMDLZ

$2.97B+10.0%

General MillsGIS

$527.2M+5.0%

Other financials

Income statement

See full

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

See full

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

See full

Operating cash flow$32.6M+2,405%

Valuation

See full

Market cap$2.39B+78.5%

Profitability

See full

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

See full

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccruedMarketingCostsCurrent.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's accrued marketing and advertising expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aurinia Pharmaceuticals's accrued marketing and advertising expenses?: Aurinia Pharmaceuticals (AUPH) reported accrued marketing and advertising expenses of $1.27M in Q1 2026.
How has Aurinia Pharmaceuticals's accrued marketing and advertising expenses changed year-over-year?: Aurinia Pharmaceuticals's accrued marketing and advertising expenses increased by 7.8% year-over-year, from $1.18M to $1.27M.